Clinical Trial Update: Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea [Phase 4]

View source ↗

Summary

Phase 4 trial investigating Bio-K+® for reducing risk of Clostridium difficile infection and antibiotic-associated diarrhea; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Diarrhea
• Clostridium Difficile Infection

Drugs mentioned

• BIO-K

Snippet

Sponsor: Bio-K Plus International Inc. | Conditions: Clostridium Difficile Infection, Antibiotic Associated Diarrhea | Phase 4 | Status: TERMINATED